Early Feasibility Study of the Velocity™ Percutaneous Arterio-Venous Fistula System for Creating Hemodialysis Vascular Access

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 8, 2025

Primary Completion Date

May 15, 2025

Study Completion Date

January 4, 2027

Conditions
Chronic Kidney Disease Requiring HemodialysisEnd Stage Renal Disease (ESRD)
Interventions
DEVICE

Velocity pAVF System

The Velocity Percutaneous Arterio-Venous Fistula System consists of a percutaneous method designed to create an arteriovenous fistula for hemodialysis vascular access.

Trial Locations (5)

32218

American Access Care of Jacksonville, Jacksonville

36301

Trinity Research Group, Dothan

76104

Texas Research Institute, Fort Worth

78207

STAR Vascular, San Antonio

92505

Apex Research, Riverside

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Venova Medical

INDUSTRY

NCT06712251 - Early Feasibility Study of the Velocity™ Percutaneous Arterio-Venous Fistula System for Creating Hemodialysis Vascular Access | Biotech Hunter | Biotech Hunter